Cleared Traditional

K103824 - HUMAN IGA LIQUID REAGENT KIT FOR USE ON...

K103824 is an FDA 510(k) clearance for HUMAN IGA LIQUID REAGENT KIT FOR USE ON..., manufactured by The Binding Site. The device is a Class 2 Immunology device with product code CFN cleared through the Traditional 510(k) pathway after a 424-day FDA review.

K103824 · The Binding Site · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
424d
Days
Class 2
Risk

K103824 is an FDA 510(k) clearance for the HUMAN IGA LIQUID REAGENT KIT FOR USE ON SPA PLUS. Classified as Method, Nephelometric, Immunoglobulins (g, A, M) (product code CFN), Class II - Special Controls.

Submitted by The Binding Site (Birmingham West Midlands, GB). The FDA issued a Cleared decision on February 27, 2012 after a review of 424 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Immunology submissions.

View all The Binding Site devices

FDA 510(k) Submission Details - K103824

510(k) Number K103824 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 2010
Decision Date February 27, 2012
Days to Decision 424 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
320d slower than avg
Panel avg: 104d · This submission: 424d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFN Device Classification - Class 2, Special Controls

Product Code CFN Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFN Method, Nephelometric, Immunoglobulins (g, A, M)

All 55
Devices cleared under the same product code (CFN) and FDA review panel - the closest regulatory comparables to K103824.
HUMAN IGG CSF KIT
K120749 · The Binding Site Group , Ltd. · May 2013
HUMAN IGM CSF KIT
K120750 · The Binding Site Group , Ltd. · May 2013
HEVYLITE HUMAN IGM KAPPA AND HEVYLITE IGM LAMBDA KIT
K113823 · The Binding Site Group , Ltd. · Mar 2013
HUMAN IGA2 KIT FOR USE ON THE SPAPLUS
K100588 · The Binding Site Group , Ltd. · Aug 2010
HEVYLITE HUMAN IGA KAPPA AND IGA LAMBDA BN KITS
K082823 · The Binding Site Group , Ltd. · Mar 2010
HUMAN IGG SUBCLASS LIQUID REAGENT KITS (FOR USE ON HITACHI 911/ 912/ 917 AND MODULAR P)
K090920 · The Binding Site, Ltd. · Dec 2009